biomark bmk m 96 96 platform (fluidigm)
fluidigm is a verified supplier 
fluidigm manufactures this product 
95
Structured Review
fluidigm
biomark bmk m 96 96 platform
Biomark Bmk M 96 96 Platform, supplied by fluidigm, used in various techniques. Bioz Stars score: 95/100, based on 716 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bmk+m+96+96+platform/96%2E96+Dynamic+Array+IFC+for+Gene+Expression/us12570745-1515-55-58
Average 95 stars, based on 716 article reviews
Biomark Bmk M 96 96 Platform, supplied by fluidigm, used in various techniques. Bioz Stars score: 95/100, based on 716 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bmk+m+96+96+platform/96%2E96+Dynamic+Array+IFC+for+Gene+Expression/us12570745-1515-55-58
Average 95 stars, based on 716 article reviews
biomark bmk m 96 96 platform - by Bioz Stars,
2026-10
95/100 stars
Images
Related Articles
Gene Expression:Article Title: Identification of an IL-22-Dependent Gene Signature as a Pharmacodynamic Biomarker Article Snippet: The pre-amplification reaction was performed at a final dilution of 0.05× for the original Taqman assay (Applied Biosystems) concentration using the following conditions: one cycle at 50 °C for 15 min and one cycle at 70 °C for 2 min, followed by 18 cycles at 95 °C for 15 s, and 60 °C for 4 min. .. The gene expression of the target genes using the available primer/probe pairs (Thermo Fisher Scientific, Rockford, IL) was measured using a Taqman Universal PCR MasterMix (Applied Biosystems) on the Polymerase Chain Reaction:Article Title: Identification of an IL-22-Dependent Gene Signature as a Pharmacodynamic Biomarker Article Snippet: The pre-amplification reaction was performed at a final dilution of 0.05× for the original Taqman assay (Applied Biosystems) concentration using the following conditions: one cycle at 50 °C for 15 min and one cycle at 70 °C for 2 min, followed by 18 cycles at 95 °C for 15 s, and 60 °C for 4 min. .. The gene expression of the target genes using the available primer/probe pairs (Thermo Fisher Scientific, Rockford, IL) was measured using a Taqman Universal PCR MasterMix (Applied Biosystems) on the Article Title: Development and Application of a Microfluidics-Based Panel in the Basal/Luminal Transcriptional Characterization of Archival Bladder Cancers Article Snippet: All Taqman primer/probe sets were included in the pre-amplification reaction at a final dilution of 0.05x original Taqman assay concentration (Applied Biosystems, Foster City, CA). .. The thermocycling conditions were as follows: 1 cycle of 50°C for 15 min, 1 cycle of 70°C for 2 min, then 14 cycles of 95°C for 15 sec and 60°C for 4 min. Pre-amplified cDNA was diluted 2-fold and then amplified using Taqman Universal PCR MasterMix (Applied Biosystems, Foster City, CA) on the Article Title: Cancer treatment with c-met antagonists and correlation of the latter with HGF expression Article Snippet: Primer/probe sets selected to detect the expression of HGF were included in a pre-amplification reaction (which included an additional 95 probe primer pairs) at a final dilution of 0.05× original Taqman assay concentration (Applied Biosystems). .. The thermocycling conditions were as follows: 1 cycle of 50° C. for 15 min, 1 cycle of 70° C. for 2 min, then 14 cycles of 95° C. for 15 sec and 60° C. for 4 min. Pre-amplified cDNA was diluted 1.94-fold and then amplified using Taqman Universal PCR MasterMix (Applied Biosystems) on the Article Title: Phase Ib study of duligotuzumab (MEHD7945A) plus cisplatin/5-fluorouracil or carboplatin/paclitaxel for first-line treatment of recurrent/metastatic squamous cell carcinoma of the head and neck. Article Snippet: BACKGROUND: This open-label, multicenter, phase Ib study assessed the safety and preliminary activity of duligotuzumab, a dualaction antibody that blocks ligand binding to human epidermal growth factor receptor 3 (HER3) and epidermal growth factor receptor, in combination with chemotherapy, in the first-line treatment of patients with recurrent/metastatic squamous cell cancer of the head and neck.. METHODS: On day 1, duligotuzumab at a dose of 1650 mg intravenously was combined with cisplatin at a dose of 100 mg/m and 5-fluorouracil at a dose of 1000 mg/m/day on days 1 to 4 in treatment arm A, or carboplatin (area under the curve, 6 mg/mL/min) and paclitaxel (at a dose of 200 mg/m) in treatment arm B.. Up to 6 cycles (21 days/cycle) were followed by duligotuzumab maintenance until disease progression or intolerable toxicity occurred. Article Title: High Heregulin Expression Is Associated with Activated HER3 and May Define an Actionable Biomarker in Patients with Squamous Cell Carcinomas of the Head and Neck Article Snippet: The pre-amplification reaction was performed at a final dilution of 0.05x original Taqman assay concentration (Applied Biosystems). .. The thermocycling conditions were as follows: 1 cycle of 50°C for 15 min, 1 cycle of 70°C for 2 min, then 14 cycles of 95°C for 15 sec and 60°C for 4 min. Pre-amplified cDNA was diluted 1.94-fold and then amplified using Taqman Universal PCR MasterMix (Applied Biosystems) on the Amplification:Article Title: Development and Application of a Microfluidics-Based Panel in the Basal/Luminal Transcriptional Characterization of Archival Bladder Cancers Article Snippet: All Taqman primer/probe sets were included in the pre-amplification reaction at a final dilution of 0.05x original Taqman assay concentration (Applied Biosystems, Foster City, CA). .. The thermocycling conditions were as follows: 1 cycle of 50°C for 15 min, 1 cycle of 70°C for 2 min, then 14 cycles of 95°C for 15 sec and 60°C for 4 min. Pre-amplified cDNA was diluted 2-fold and then amplified using Taqman Universal PCR MasterMix (Applied Biosystems, Foster City, CA) on the Article Title: Cancer treatment with c-met antagonists and correlation of the latter with HGF expression Article Snippet: Primer/probe sets selected to detect the expression of HGF were included in a pre-amplification reaction (which included an additional 95 probe primer pairs) at a final dilution of 0.05× original Taqman assay concentration (Applied Biosystems). .. The thermocycling conditions were as follows: 1 cycle of 50° C. for 15 min, 1 cycle of 70° C. for 2 min, then 14 cycles of 95° C. for 15 sec and 60° C. for 4 min. Pre-amplified cDNA was diluted 1.94-fold and then amplified using Taqman Universal PCR MasterMix (Applied Biosystems) on the Article Title: Phase Ib study of duligotuzumab (MEHD7945A) plus cisplatin/5-fluorouracil or carboplatin/paclitaxel for first-line treatment of recurrent/metastatic squamous cell carcinoma of the head and neck. Article Snippet: BACKGROUND: This open-label, multicenter, phase Ib study assessed the safety and preliminary activity of duligotuzumab, a dualaction antibody that blocks ligand binding to human epidermal growth factor receptor 3 (HER3) and epidermal growth factor receptor, in combination with chemotherapy, in the first-line treatment of patients with recurrent/metastatic squamous cell cancer of the head and neck.. METHODS: On day 1, duligotuzumab at a dose of 1650 mg intravenously was combined with cisplatin at a dose of 100 mg/m and 5-fluorouracil at a dose of 1000 mg/m/day on days 1 to 4 in treatment arm A, or carboplatin (area under the curve, 6 mg/mL/min) and paclitaxel (at a dose of 200 mg/m) in treatment arm B.. Up to 6 cycles (21 days/cycle) were followed by duligotuzumab maintenance until disease progression or intolerable toxicity occurred. Article Title: High Heregulin Expression Is Associated with Activated HER3 and May Define an Actionable Biomarker in Patients with Squamous Cell Carcinomas of the Head and Neck Article Snippet: The pre-amplification reaction was performed at a final dilution of 0.05x original Taqman assay concentration (Applied Biosystems). .. The thermocycling conditions were as follows: 1 cycle of 50°C for 15 min, 1 cycle of 70°C for 2 min, then 14 cycles of 95°C for 15 sec and 60°C for 4 min. Pre-amplified cDNA was diluted 1.94-fold and then amplified using Taqman Universal PCR MasterMix (Applied Biosystems) on the |